Skip to content
Screener

Zoetis ZTS EPS (Diluted)

EPS (Diluted) at other companies

Merck & Co. logo
Merck & Co.MRK
-$0.54-131%
Neogen logo
NeogenNEOG
-$0.08-60.0%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$4.27+17.6%
Phibro Animal Health Corporation logo
Phibro Animal Health CorporationPAHC
$0.53+23.3%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$0.11+450%
Tractor Supply Company logo
Tractor Supply CompanyTSCO
$0.69-14.8%

Other financials

Income statement

See full
Revenue$2.5B-0.2%
Gross profit$1.8B-0.8%
Net income$691.0M-4.8%

Balance sheet

See full
Cash & equivalents$1.5B-9.6%
Total debt$10.0B+47.1%
Total equity$3.1B-36.7%
Total assets$15.1B+4.1%

Cash flow

See full
Operating cash flow$655.0M+8.3%
CapEx$117.0M-19.9%
Free cash flow$538.0M+17.2%

Valuation

See full
Market cap$32.03B-53.5%
Enterprise value$40.55B-45.2%
P/E12.3×-14.3×
P/S3.4×-4.0×

Profitability

See full
Gross margin71.5%+0.2pp
Net margin27.5%-0.1pp
FCF margin24.3%+0.1pp

Returns & leverage

See full
Return on equity64.4%+12.3pp
Debt / equity3.2×+1.8×
Current ratio3.1×+1.3×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Zoetis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 2:32 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001555280-26-000040
(MILLIONS OF DOLLARS AND SHARES, EXCEPT PER SHARE DATA)Three Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Less: Net income/(loss) attributable to noncontrolling interests
Net income attributable to Zoetis Inc.$691$726$1,292$1,328
Denominator
Weighted-average common shares outstanding417.6445.1419.9446.3
Common stock equivalents: stock options, RSUs, PSUs and DSUs0.10.40.20.4
Weighted-average common and potential dilutive shares outstanding417.7445.5420.1446.7
Earnings per share attributable to Zoetis Inc. stockholders—basic$1.65$1.63$3.08$2.98
Earnings per share attributable to Zoetis Inc. stockholders—diluted$1.65$1.63$3.08$2.97

Item 1. Financial Statements

FAQ

What is Zoetis's EPS (diluted)?
Zoetis (ZTS) reported EPS (diluted) of $1.65 in Q2 2026.
How has Zoetis's EPS (diluted) changed year-over-year?
Zoetis's EPS (diluted) increased by 1.2% year-over-year, from $1.63 to $1.65.
What is the long-term trend for Zoetis's EPS (diluted)?
Over 4 years (2021 to 2025), Zoetis's EPS (diluted) has grown at a 8.7% compound annual growth rate (CAGR), from $4.27 to $5.97.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Zoetis's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude